ArticleJournal of bone oncology2025

Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation.

Shaochun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.